100 related articles for article (PubMed ID: 29195903)
21. Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1.
Ben-Ami O; Friedman D; Leshkowitz D; Goldenberg D; Orlovsky K; Pencovich N; Lotem J; Tanay A; Groner Y
Cell Rep; 2013 Sep; 4(6):1131-43. PubMed ID: 24055056
[TBL] [Abstract][Full Text] [Related]
22. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
23. [Acute myeloid leukemia with t(3;21)(q13;q22), a novel simple variant of the 21q22/RUNX1 translocation].
Tsuruoka Y; Sakai H; Uchida A; Uemura Y; Sato K; Yokoi S; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Tomita N; Inoue Y; Miura I
Rinsho Ketsueki; 2017; 58(1):3-8. PubMed ID: 28190862
[TBL] [Abstract][Full Text] [Related]
24. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
Abe A; Yamamoto Y; Katsumi A; Okamoto A; Tokuda M; Inaguma Y; Yamamoto K; Yanada M; Kanie T; Tomita A; Akatsuka Y; Okamoto M; Kameyama T; Mayeda A; Emi N
Int J Hematol; 2018 Aug; 108(2):208-212. PubMed ID: 29264741
[TBL] [Abstract][Full Text] [Related]
25. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
26. In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline.
Mendler JH; Maharry K; Becker H; Eisfeld AK; Senter L; Mrózek K; Kohlschmidt J; Metzeler KH; Schwind S; Whitman SP; Khalife J; Caligiuri MA; Klisovic RB; Moore JO; Carter TH; Marcucci G; Bloomfield CD
Haematologica; 2013 Aug; 98(8):e92-4. PubMed ID: 23753029
[No Abstract] [Full Text] [Related]
27. Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees.
Buijs A; Poot M; van der Crabben S; van der Zwaag B; van Binsbergen E; van Roosmalen MJ; Tavakoli-Yaraki M; de Weerdt O; Nieuwenhuis HK; van Gijn M; Kloosterman WP
Leukemia; 2012 Sep; 26(9):2151-4. PubMed ID: 22430633
[No Abstract] [Full Text] [Related]
28. Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases.
Fasan A; Haferlach C; Kohlmann A; Dicker F; Eder C; Kern W; Haferlach T; Schnittger S
Haematologica; 2014 Feb; 99(2):e20-1. PubMed ID: 24497565
[No Abstract] [Full Text] [Related]
29. Identification of a novel RUNX1-TACC1 fusion transcript in acute myeloid leukaemia.
Yang RY; Yang CX; Lang XP; Duan LJ; Wang RJ; Zhou W; Wu GS; Li Y; Qian T; Xiao S; Fu L
Br J Haematol; 2020 Apr; 189(2):e52-e56. PubMed ID: 32108319
[No Abstract] [Full Text] [Related]
30. RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.
Carratt SA; Kong GL; Coblentz C; Schonrock Z; Maloney L; Weeder B; Yashar W; Callahan R; Blaylock H; Coleman C; Coleman D; Braun TP; Maxson JE
Leukemia; 2023 May; 37(5):1141-1146. PubMed ID: 36894620
[No Abstract] [Full Text] [Related]
31. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Schafhausen P; Dierlamm J; Bokemeyer C; Bruemmendorf TH; Bacher U; Zander AR; Schnittger S; Hochhaus A
Cancer Genet Cytogenet; 2009 Feb; 189(1):63-7. PubMed ID: 19167615
[No Abstract] [Full Text] [Related]
32. RUNX1 rearrangements in acute myeloblastic leukemia relapsing after hematopoietic stem cell transplantation.
Nadal N; Stephan JL; Cornillon J; Guyotat D; Flandrin P; Campos L
Cancer Genet Cytogenet; 2008 Jan; 180(2):168-9. PubMed ID: 18206548
[No Abstract] [Full Text] [Related]
33. [Near-tetraploidy acute myeloid leukemia with RUNX1-RUNX1T1 rearrangement due to cryptic t(8;21)].
Im M; Lee JK; Lee DY; Hong YJ; Hong SI; Kang HJ; Chang YH
Korean J Lab Med; 2009 Dec; 29(6):510-4. PubMed ID: 20046081
[TBL] [Abstract][Full Text] [Related]
34. AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia.
Dunne J; Mannari D; Farzaneh T; Gessner A; van Delft FW; Heidenreich O; Young BD; Gascoyne DM
Leukemia; 2012 May; 26(5):1131-5. PubMed ID: 22064348
[No Abstract] [Full Text] [Related]
35. Identification of a novel fusion gene, RUNX1-PRPF38A, in acute myeloid leukemia.
Wang H; Chen X; Xu Z; Tan Y; Qi X; Zhang L; Xu A; Ren F
Int J Lab Hematol; 2017 Aug; 39(4):e90-e93. PubMed ID: 28263028
[No Abstract] [Full Text] [Related]
36. RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.
Panagopoulos I; Torkildsen S; Gorunova L; Ulvmoen A; Tierens A; Zeller B; Heim S
Oncol Rep; 2016 Nov; 36(5):2481-2488. PubMed ID: 27667292
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
Foster N; Paulsson K; Sales M; Cunningham J; Groves M; O'Connor N; Begum S; Stubbs T; McMullan DJ; Griffiths M; Pratt N; Tauro S
Br J Haematol; 2010 Mar; 148(6):938-43. PubMed ID: 20064152
[TBL] [Abstract][Full Text] [Related]
38. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
Rodriguez-Perales S; Torres-Ruiz R; Suela J; Acquadro F; Martin MC; Yebra E; Ramirez JC; Alvarez S; Cigudosa JC
Oncogene; 2016 Jan; 35(1):125-34. PubMed ID: 25798834
[TBL] [Abstract][Full Text] [Related]
39. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
[TBL] [Abstract][Full Text] [Related]
40. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
